These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

274 related items for PubMed ID: 25612167

  • 21. [Multiple sclerosis in children: clarifying its place among the demyelinating spectrum].
    Peña JA, Montiel-Nava C, Ravelo ME, González S, Mora La-Cruz E.
    Invest Clin; 2006 Dec; 47(4):413-25. PubMed ID: 17176909
    [Abstract] [Full Text] [Related]

  • 22. Assessment of lesion pathology in a new animal model of MS by multiparametric MRI and DTI.
    Boretius S, Escher A, Dallenga T, Wrzos C, Tammer R, Brück W, Nessler S, Frahm J, Stadelmann C.
    Neuroimage; 2012 Feb 01; 59(3):2678-88. PubMed ID: 21914485
    [Abstract] [Full Text] [Related]

  • 23. In-vivo evidence for stable neuroaxonal damage in the brain of patients with benign multiple sclerosis.
    Benedetti B, Rovaris M, Rocca MA, Caputo D, Zaffaroni M, Capra R, Bertolotto A, Martinelli V, Comi G, Filippi M.
    Mult Scler; 2009 Jul 01; 15(7):789-94. PubMed ID: 19465450
    [Abstract] [Full Text] [Related]

  • 24. [Axonal damage in multiple sclerosis].
    Bartosik-Psujek H, Stelmasiak Z.
    Neurol Neurochir Pol; 2002 Jul 01; 36(3):505-12. PubMed ID: 12185807
    [Abstract] [Full Text] [Related]

  • 25. Neurological disability correlates with spinal cord axonal loss and reduced N-acetyl aspartate in chronic multiple sclerosis patients.
    Bjartmar C, Kidd G, Mörk S, Rudick R, Trapp BD.
    Ann Neurol; 2000 Dec 01; 48(6):893-901. PubMed ID: 11117546
    [Abstract] [Full Text] [Related]

  • 26. MRI parameters for prediction of multiple sclerosis diagnosis in children with acute CNS demyelination: a prospective national cohort study.
    Verhey LH, Branson HM, Shroff MM, Callen DJ, Sled JG, Narayanan S, Sadovnick AD, Bar-Or A, Arnold DL, Marrie RA, Banwell B, Canadian Pediatric Demyelinating Disease Network.
    Lancet Neurol; 2011 Dec 01; 10(12):1065-73. PubMed ID: 22067635
    [Abstract] [Full Text] [Related]

  • 27. Risk of multiple sclerosis after a first demyelinating syndrome in an Australian Paediatric cohort: clinical, radiological features and application of the McDonald 2010 MRI criteria.
    Tantsis EM, Prelog K, Brilot F, Dale RC.
    Mult Scler; 2013 Nov 01; 19(13):1749-59. PubMed ID: 23579092
    [Abstract] [Full Text] [Related]

  • 28. Axonal injury in children after motor vehicle crashes: extent, distribution, and size of axonal swellings using beta-APP immunohistochemistry.
    Gorrie C, Oakes S, Duflou J, Blumbergs P, Waite PM.
    J Neurotrauma; 2002 Oct 01; 19(10):1171-82. PubMed ID: 12427326
    [Abstract] [Full Text] [Related]

  • 29. Sodium channel expression within chronic multiple sclerosis plaques.
    Black JA, Newcombe J, Trapp BD, Waxman SG.
    J Neuropathol Exp Neurol; 2007 Sep 01; 66(9):828-37. PubMed ID: 17805013
    [Abstract] [Full Text] [Related]

  • 30. Effect of oral cladribine on time to conversion to clinically definite multiple sclerosis in patients with a first demyelinating event (ORACLE MS): a phase 3 randomised trial.
    Leist TP, Comi G, Cree BA, Coyle PK, Freedman MS, Hartung HP, Vermersch P, Casset-Semanaz F, Scaramozza M, oral cladribine for early MS (ORACLE MS) Study Group.
    Lancet Neurol; 2014 Mar 01; 13(3):257-67. PubMed ID: 24502830
    [Abstract] [Full Text] [Related]

  • 31. Remyelination capacity of the MS brain decreases with disease chronicity.
    Goldschmidt T, Antel J, König FB, Brück W, Kuhlmann T.
    Neurology; 2009 Jun 02; 72(22):1914-21. PubMed ID: 19487649
    [Abstract] [Full Text] [Related]

  • 32. MRI in the diagnosis of pediatric multiple sclerosis.
    Callen DJ, Shroff MM, Branson HM, Lotze T, Li DK, Stephens D, Banwell BL.
    Neurology; 2009 Mar 17; 72(11):961-7. PubMed ID: 19038852
    [Abstract] [Full Text] [Related]

  • 33. Difference in disease burden and activity in pediatric patients on brain magnetic resonance imaging at time of multiple sclerosis onset vs adults.
    Waubant E, Chabas D, Okuda DT, Glenn O, Mowry E, Henry RG, Strober JB, Soares B, Wintermark M, Pelletier D.
    Arch Neurol; 2009 Aug 17; 66(8):967-71. PubMed ID: 19667217
    [Abstract] [Full Text] [Related]

  • 34. Diagnostic utility of aquaporin-4 in the analysis of active demyelinating lesions.
    Popescu BF, Guo Y, Jentoft ME, Parisi JE, Lennon VA, Pittock SJ, Weinshenker BG, Wingerchuk DM, Giannini C, Metz I, Brück W, Shuster EA, Carter J, Boyd CD, Clardy SL, Cohen BA, Lucchinetti CF.
    Neurology; 2015 Jan 13; 84(2):148-58. PubMed ID: 25503621
    [Abstract] [Full Text] [Related]

  • 35. Characterization of tissue damage in multiple sclerosis by nuclear magnetic resonance.
    Barkhof F, van Walderveen M.
    Philos Trans R Soc Lond B Biol Sci; 1999 Oct 29; 354(1390):1675-86. PubMed ID: 10603619
    [Abstract] [Full Text] [Related]

  • 36. Epitope spreading as an early pathogenic event in pediatric multiple sclerosis.
    Quintana FJ, Patel B, Yeste A, Nyirenda M, Kenison J, Rahbari R, Fetco D, Hussain M, O'Mahony J, Magalhaes S, McGowan M, Johnson T, Rajasekharan S, Narayanan S, Arnold DL, Weiner HL, Banwell B, Bar-Or A, Canadian Pediatric Demyelinating Disease Network.
    Neurology; 2014 Dec 09; 83(24):2219-26. PubMed ID: 25381299
    [Abstract] [Full Text] [Related]

  • 37. Pediatric optic neuritis: brain MRI abnormalities and risk of multiple sclerosis.
    Bonhomme GR, Waldman AT, Balcer LJ, Daniels AB, Tennekoon GI, Forman S, Galetta SL, Liu GT.
    Neurology; 2009 Mar 10; 72(10):881-5. PubMed ID: 19273821
    [Abstract] [Full Text] [Related]

  • 38. Axonal damage in acute multiple sclerosis lesions.
    Ferguson B, Matyszak MK, Esiri MM, Perry VH.
    Brain; 1997 Mar 10; 120 ( Pt 3)():393-9. PubMed ID: 9126051
    [Abstract] [Full Text] [Related]

  • 39. Homogeneity of active demyelinating lesions in established multiple sclerosis.
    Breij EC, Brink BP, Veerhuis R, van den Berg C, Vloet R, Yan R, Dijkstra CD, van der Valk P, Bö L.
    Ann Neurol; 2008 Jan 10; 63(1):16-25. PubMed ID: 18232012
    [Abstract] [Full Text] [Related]

  • 40. Beta-Interferon treatment does not always slow the progression of axonal injury in multiple sclerosis.
    Parry A, Corkill R, Blamire AM, Palace J, Narayanan S, Arnold D, Styles P, Matthews PM.
    J Neurol; 2003 Feb 10; 250(2):171-8. PubMed ID: 12574947
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.